HK Stock Market Move | BAO PHARMA-B (02659) rose more than 15% during the trading day. BJ044 is expected to form a systematic replacement for existing urine extraction products.
Baoji Pharmaceutical Industry-B (02659) rose more than 15% during the day, as of the time of publication, it has risen by 10.97% to 21.14 Hong Kong dollars, with a turnover of 62.3483 million Hong Kong dollars.
BAO PHARMA-B(02659) rose more than 15% during trading hours, and at the time of writing, it was up 10.97% at 21.14 Hong Kong dollars, with a trading volume of 62.3483 million Hong Kong dollars.
On the news front, Bao Ji Pharmaceuticals recently announced that its independently developed BJ044 injection (recombinant ursodeoxycholic acid) has officially received approval for clinical trial application (IND) from the National Medical Products Administration (NMPA). BJ044 is the world's first recombinant ursodeoxycholic acid product developed using synthetic biology technology.
It is worth noting that, with its comprehensive advantages in purity, safety, consistency, and cost-effectiveness, BJ044 has the potential to systematically replace existing urine-extracted products. Analysts point out that for Bao Ji Pharmaceuticals, the approval of BJ044's IND is another validation of its synthetic biology platform technology strength, and it is also another key milestone in realizing the pipeline value after SJ02 and KJ017.
Related Articles
HK Stock Market Move | DONGYUE GROUP (00189) fell more than 7% after the profit soared, expected to increase by more than 30% in the first half of the year. The company has withdrawn its application for IPO on the Sci-Tech Innovation Board in the future.
A-share midday review | Index differentiation, Shanghai index up with volume, more than 4500 individual stocks rose, "old listed stocks" rebounded in shock.
HK Stock Market Move | Guangdong Dtech Technology (01377) rose more than 17% in early trading, entering the market on the first day of listing. The company benefits from AI PCB expansion production.
HK Stock Market Move | DONGYUE GROUP (00189) fell more than 7% after the profit soared, expected to increase by more than 30% in the first half of the year. The company has withdrawn its application for IPO on the Sci-Tech Innovation Board in the future.
A-share midday review | Index differentiation, Shanghai index up with volume, more than 4500 individual stocks rose, "old listed stocks" rebounded in shock.
HK Stock Market Move | Guangdong Dtech Technology (01377) rose more than 17% in early trading, entering the market on the first day of listing. The company benefits from AI PCB expansion production.
RECOMMEND
